Cover Image

Ticarcillin Hypersusceptibility in Pseudomonas Aeruginosa in Cystic Fibrosis

<p><strong>Background:</strong> A subpopulation of Pseudomonas aeruginosa (PsA) exists in cysticfibrosis (CF) patients that is hypersusceptible to ticarcillin, a carboxypenicillin, in vitro (Tichs strain) defined as a minimum inhibitory concentration (MIC) ≤4μg/ml. </...

Full description

Saved in:

Bibliographic Details
Main Authors:	IT Hettiarachchi (Author), T O'Sullivan (Author), M Wootton (Author), A Smith (Author), J Duckers (Author), R Dhillon (Author)
Format:	Book
Published:	Archives of Pulmonology and Respiratory Care - Peertechz Publications, 2017-09-13.
Subjects:	Research Article
Online Access:	Connect to this object online.
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Inflammatory Markers in Cystic Fibrosis Patients with Lung Pseudomonas Aeruginosa Infection
by: A. L. Pukhalsky, et al.
Published: (1999)

Virulence of <i>Pseudomonas aeruginosa</i> in Cystic Fibrosis: Relationships between Normoxia and Anoxia Lifestyle
by: Rosanna Papa, et al.
Published: (2023)

Bacteriophage-based therapy in cystic fibrosis-associated Pseudomonas aeruginosa infections: rationale and current status
by: Hraiech S, et al.
Published: (2015)

Polymicrobial Interactions in the Cystic Fibrosis Airway Microbiome Impact the Antimicrobial Susceptibility of <i>Pseudomonas aeruginosa</i>
by: Emma Reece, et al.
Published: (2021)

Caracterización, por RAPD-PCR, de aislados de Pseudomonas aeruginosa obtenidos de pacientes con fibrosis quística RAPD-PCR characterization of Pseudomonas aeruginosa strains obtained from cystic fibrosis patients
by: Maribel Ortiz-Herrera, et al.
Published: (2004)

Vitamin D inhibits pro-inflammatory cytokines in the airways of cystic fibrosis patients infected by Pseudomonas aeruginosa- pilot study
by: M. Olszowiec-Chlebna, et al.
Published: (2019)

THE PERFORMANCE OF A LONG-TERM ANTIBACTERIAL THERAPY IN CHILDREN WITH CYSTIC FIBROSIS DURING PRIMARY PLATING OF PSEUDOMONAS AERUGINOSA
by: О. I. Simonova, et al.
Published: (2014)

Ceftolozane/Tazobactam for Treating Children With Exacerbations of Cystic Fibrosis Due to Pseudomonas aeruginosa: A Review of Available Data
by: Silvia Garazzino, et al.
Published: (2020)

Pseudomonas aeruginosa isolates from cystic fibrosis patients induce neutrophil extracellular traps with different morphologies that could correlate with their disease severity
by: S. Martínez-Alemán, et al.
Published: (2020)

Myeloperoxidase and eosinophil cationic protein in serum and sputum during antibiotic treatment in cystic fibrosis patients with Pseudomonas aeruginosa infection
by: B. Niggemann, et al.
Published: (1995)

SOLUTION OF THE PROBLEM OF PSEUDOMONAS INFECTION IN CHILDREN WITH CYSTIC FIBROSIS
by: O. I. Simonova, et al.
Published: (2014)

Contemporary analysis of ETEST for antibiotic susceptibility and minimum inhibitory concentration agreement against Pseudomonas aeruginosa from patients with cystic fibrosis
by: Maxwell J. Lasko, et al.
Published: (2021)

Evidence for the Involvement of Lipid Rafts and Plasma Membrane Sphingolipid Hydrolases in Pseudomonas aeruginosa Infection of Cystic Fibrosis Bronchial Epithelial Cells
by: Domitilla Schiumarini, et al.
Published: (2017)

Activity of Delafloxacin and Comparator Fluoroquinolones against Multidrug-Resistant <i>Pseudomonas aeruginosa</i> in an In Vitro Cystic Fibrosis Sputum Model
by: Vaughn D. Craddock, et al.
Published: (2023)

Impact of Growth Conditions on High-Throughput Identification of Repurposing Drugs for <i>Pseudomonas aeruginosa</i> Cystic Fibrosis Lung Infections
by: Giovanni Di Bonaventura, et al.
Published: (2024)

Early detection of <it>Pseudomonas aeruginosa </it>- comparison of conventional versus molecular (PCR) detection directly from adult patients with cystic fibrosis (CF)
by: Moore John E, et al.
Published: (2004)

New Sequence Type ST3449 in Multidrug-Resistant <i>Pseudomonas aeruginosa</i> Isolates from a Cystic Fibrosis Patient
by: Catalina Díaz-Ríos, et al.
Published: (2021)

Current and Emerging Inhaled Antibiotics for Chronic Pulmonary <i>Pseudomonas aeruginosa</i> and <i>Staphylococcus aureus</i> Infections in Cystic Fibrosis
by: Danni Li, et al.
Published: (2023)

Antibacterial and Antibiofilm Effects of Lactobacilli Strains against Clinical Isolates of <i>Pseudomonas aeruginosa</i> under Conditions Relevant to Cystic Fibrosis
by: Giovanna Batoni, et al.
Published: (2023)

Advancing Antibiotic Residue Analysis: LC-MS/MS Methodology for Ticarcillin Degradation Products in Tomato Leaves
by: Muhammad K. Hakeem, et al.
Published: (2024)

Investigation of Phagocyte Functions in Pseudomonas-Colonized Cystic Fibrosis Patients
by: Handan Duman Şenol, et al.
Published: (2024)

Pseudomonas Aeruginosa An Armory Within
Published: (2019)

Endotoxin of Pseudomonas Aeruginosa
by: Nualchan Charoenkul
Published: (2014)

Lytic Bacteriophage Is a Promising Adjunct to Common Antibiotics across Cystic Fibrosis Clinical Strains and Culture Models of <i>Pseudomonas aeruginosa</i> Infection
by: Isaac Martin, et al.
Published: (2023)

PROBLEMS AND PERSPECTIVES OF ANTIBACTERIAL THERAPY OF CHRONIC PSEUDOMONAS INFECTION IN PATIENTS WITH CYSTIC FIBROSIS
by: S.Yu. Semykin, et al.
Published: (2010)

PROBLEMS AND PERSPECTIVES OF ANTIBACTERIAL THERAPY OF CHRONIC PSEUDOMONAS INFECTION IN PATIENTS WITH CYSTIC FIBROSIS
by: S.Yu. Semykin, et al.
Published: (2010)

Sinonasal inhalation of tobramycin vibrating aerosol in cystic fibrosis patients with upper airway Pseudomonas aeruginosa colonization: results of a randomized, double-blind, placebo-controlled pilot study
by: Mainz JG, et al.
Published: (2014)

Pseudomonas aeruginosa multirresistente: um problema endêmico no Brasil Multidrug-resistant Pseudomonas aeruginosa: an endemic problem in Brazil
by: Patrícia R. Neves, et al.
Published: (2011)

Antimicrobial Synergy Testing: Comparing the Tobramycin and Ceftazidime Gradient Diffusion Methodology Used in Assessing Synergy in Cystic Fibrosis-Derived Multidrug-Resistant <i>Pseudomonas aeruginosa</i>
by: Ijeoma N. Okoliegbe, et al.
Published: (2021)

Pseudomonas aeruginosa necrotizing bronchopneumonia
by: Ranjit I Kylat
Published: (2021)

Assessment of the microbial load of airway clearance devices used by a cohort of children with cystic fibrosis
by: B. Linnane, et al.
Published: (2021)

Evaluation of Aerosol Therapy during the Escalation of Care in a Model of Adult Cystic Fibrosis
by: Elena Fernández Fernández, et al.
Published: (2021)

Antibiofilm activity of aminopropanol derivatives against Pseudomonas aeruginosa
by: D. M. Dudikova, et al.
Published: (2018)

Novel understandings of host cell mechanisms involved in chronic lung infection: Pseudomonas aeruginosa in the cystic fibrotic lung
by: Peter Anto Johnson
Published: (2019)

Treatment Heterogeneity in <i>Pseudomonas aeruginosa</i> Pneumonia
by: Aisling R. Caffrey, et al.
Published: (2022)

Immunological considerations in the development of Pseudomonas aeruginosa vaccines
by: Sarah M. Baker, et al.
Published: (2020)

Non-Linear Pharmacokinetics of Oral Roscovitine (Seliciclib) in Cystic Fibrosis Patients Chronically Infected with <i>Pseudomonas aeruginosa</i>: A Study on Population Pharmacokinetics with Monte Carlo Simulations
by: Cyril Leven, et al.
Published: (2020)

How to manage Pseudomonas aeruginosa infections
by: Matteo Bassetti, et al.
Published: (2018)

Adherence ability of Pseudomonas aeruginosa to intestinal epithelium of Rabbit
by: A.H. Al-Hamadani, et al.
Published: (2007)

<i>Pseudomonas aeruginosa</i> Biofilm Formation, Infections and Treatments
Published: (2021)